
Anlon Healthcare
Mainboard₹14,924 / 164 Shares
IPO Live Subscription Details (times)
Bids below ₹10L: 16.69x
NII Total: 10.61
IPO Details
Anlon Healthcare IPO is priced between ₹86-91 per equity share, with a face value of ₹10 per share. The company's equity shares will be listed on the Mainboard, and Kfin Technologies Ltd is managing the issue as the registrar.
The IPO bidding period opened on 26 Aug, 2025, and closed on 29 Aug, 2025. The allotment results will be announced on 1 Sep, 2025, with a tentative listing date set for 3 Sep, 2025.
The total issue comprises 1,33,00,000 shares, amounting to ₹121.03 Cr.
Anlon Healthcare IPO Highlights
IPO Date | Listing Date | Face Value | Price Band | Lot Size | Fresh Issue | Offer for Sale | Listing At |
---|---|---|---|---|---|---|---|
Aug 26, 2025 - Aug 29, 2025 | 3 Sep, 2025 | ₹10 Per Equity Share | ₹86-91 per equity share | 164 Shares | Shares | - | BSE, NSE |
Anlon Healthcare IPO Timeline
Issue Price
₹86-91 per equity shareFace Value
₹10 Per Equity ShareListing at Group
BSE, NSERegistrar
Kfin Technologies LtdMarket Lot
Retail: 164 Shares (₹14,924/-)S-HNI: 2,296 Shares (₹2,08,936/-)
B-HNI: 11,152 Shares (₹10,14,832/-)
Lead Manager
Interactive Financial Services LtdIssue Size
1,33,00,000 shares(aggregating up to ₹121.03 Cr)Retail Portion
10% (Number of Retail Applications: 8,110 Approx),(Number of S-HNI Applications : 290 Approx),(Number of B-HNI Applications : 579 Approx)Subscription
7.10 timesAnlon Healthcare IPO Financial Information
Period Ended | Assets | Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
---|---|---|---|---|---|---|
31 Mar 25 | 181.30 | 120.46 | 20.52 | 80.42 | 40.57 | 58.35 |
31 Mar 24 | 128.00 | 66.69 | 9.66 | 21.03 | 5.03 | 74.56 |
31 Mar 23 | 111.55 | 113.12 | 5.82 | 7.37 | -4.63 | 66.39 |
All values are in ₹ Cr.
Anlon Healthcare IPO Valuations
EPS PRE IPO ₹5.15/- | EPS POST IPO ₹3.86/- | PE PRE IPO 17.67 | PE POST IPO 23.57 | ROE 40.45% |
ROCE 21.93% | DEBT EQUITY 0.73 | RONW 25.51% | PAT MARGIN 17.06% | PRICE TO BOOK VALUE 4.51 |
About Company
Anlon Healthcare Limited was incorporated in 2013. It is a chemical manufacturing firm involved in the production of Pharma Intermediates and active pharmaceutical ingredients (APIs).
The firm produces high-purity pharmaceutical intermediates (for API synthesis) and active pharmaceutical ingredients (utilized in formulations for pharmaceuticals, nutraceuticals, personal care, and animal health products).The firm deals in pharma intermediates, APIs for drugs, nutraceuticals, personal care, and veterinary products, all of which are produced to Indian and international pharmacopeia standards such as IP, BP, EP, JP, and USP.Besides producing Pharma Intermediates and APIs to international specifications, the firm now provides contract manufacturing of complex chemicals beyond purity levels and lowering impurities to suit particular customers' requirements.
The firm has been approved by ANVISA, NMPA, and PMDA for loxoprofen sodium dihydrate and loxoprofen acid APIs in terms of Drug Master File (DMF). The firm has submitted 21 DMFs to worldwide authorities and is submitting for Ketoprofen and Dexketoprofen Trometamol approvals.65 commercial products, 28 pilot-scale products, and 49 lab-scale products are part of the firm's portfolio.
The firm maintains product quality through thorough testing, analysis, and process optimization. Backed by four laboratories, the 34-strong team, which comprises 24 science graduates, guarantees that products meet customer and industry requirements.
Anlon Healthcare IPO Subscription Details
As on | QIB | NII bNII sNII | Retail | Total |
---|---|---|---|---|
Shares Offered / Reserved | 99,75,000 | 19,95,000 13,30,000 6,65,000 | 13,30,000 | 1,33,00,000 |
Day 1 - 26-08-25 05:00 PM | 0.91 x | 0.71 0.48 x 1.17 x | 8.99 x | 1.69 x |
Day 2 - 28-08-25 05:00 PM | 1.01 x | 2.09 1.38 x 3.51 x | 22.32 x | 3.30 x |
Day 3 - 28-08-25 05:00 PM | 1.07 x | 10.60 7.56 x 16.66 x | 47.04 x | 7.10 x |
Retail:42.0x
BHNI:1.5x
SHNI:16.0x times
Anlon Healthcare IPO - Issue Objectives
- Funding capital expenditure requirements for Proposed Expansion
- Full or part repayment and/or prepayment of certain outstanding secured borrowingssecured borrowing (term loan)availed by the Company
- Funding the working capital requirements of the Company
- General corporate purposes
Anlon Healthcare
101/102, Silvercoin Complex, Opp.Crystal Mall,Kalawad Road Rajkot, Gujarat, 360005Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: ahl.ipo@kfintech.com